The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-19. Anything still debated is marked as such rather than presented as settled.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
protein A polymeric macromolecule composed of one or more long chains of amino acids linked by peptide bonds. Proteins are the three-dimensional structures created when these chains fold into specific higher-order arrangements following translation, and it is this folded structure which determines a protein's chemical activity and hence its biological function. Ubiquitous and fundamental in all living organisms, proteins are the primary means by which the activities of life are performed, participating in the vast majority of the biochemical reactions that occur inside and outside of cells. They are often classified according to the type(s) of reaction(s) they facilitate or catalyze, by the chemical substrate(s) they act upon, or by their functional role in cellular activity; e.g. as structural proteins, motor proteins, enzymes, transcription factors, or links within biochemical pathways.
== Coaching team == Zverev has been coached by his parents since he was very young. His mother was initially his primary coach before his father took over at some point. Zverev made the decision to hire former world No. 1 Juan Carlos Ferrero at the Washington Open in the summer of 2017. He fired Ferrero following the 2018 Australian Open after Ferrero criticized the rest of Zverev's coaching team. Ivan Lendl, another former world No. 1, joined Zverev's team in August 2018. They split up in July 2019 due to disappointing results and personal differences. Zverev has stated that Lendl was more interested in his dog or his golf game than in professional coaching. In 2020, Zverev started to work with former World Number 3 and 2013 French Open Finalist David Ferrer. They announced their split in January 2021. Zverev's coaching team also includes physio Hugo Gravil. Fitness trainer Jez Green, who previously worked with Andy Murray, also worked with Zverev beginning 2013. Green departed Zverev's team in 2021 after working with him for around seven years.
For the ninth patient, they introduced a surgical instrument called a leucotome; this was a cannula that was 11 centimetres (4.3 in) in length and 2 centimetres (0.79 in) in diameter. It had a retractable wire loop at one end that, when rotated, produced a 1 centimetre (0.39 in) diameter circular lesion in the white matter of the frontal lobe. Typically, six lesions were cut into each lobe, but, if they were dissatisfied with the results, Lima might perform several procedures, each producing multiple lesions in the left and right frontal lobes. By the conclusion of this first run of leucotomies in February 1936, Moniz and Lima had operated on twenty patients with an average period of one week between each procedure; Moniz published his findings with great haste in March of the same year. The patients were aged between 27 and 62 years of age; twelve were female, and eight were male. Nine of the patients were diagnosed with depression, six with schizophrenia, two with panic disorder, and one each with mania, catatonia and manic-depression. Their most prominent symptoms were anxiety and agitation. The duration of their illness before the procedure varied from as little as four weeks to as much as 22 years, although all but four had been ill for at least one year. Patients were normally operated on the day they arrived at Moniz's clinic and returned within ten days to the Miguel Bombarda Mental Hospital. A perfunctory post-operative follow-up assessment took place anywhere from one to ten weeks following surgery.
=== Imaging === Ultrasound, particularly duplex ultrasound, is the most usual and widely used way of viewing veins in the diagnosis of venous disease. Venography is an invasive procedure that uses a catheter to deliver a contrast agent in giving an X-ray of veins. An augmented reality healthcare application is a near-infrared vein finder that films subcutaneous veins, and projects their image either onto a screen or onto the person's skin.
== Cultivation == The sacred lotus grows in water about 2.5 m (8 ft) to 30 cm (12 in) deep. In colder climates, a deeper water level protects the tubers more effectively, and improves growth and flowering. The sacred lotus germinates at temperatures above 13 °C (55 °F). Most varieties are not naturally cold-hardy, but may readily adapt to living outdoors year-round in USDA hardiness zones 6 through 11 (with some growers having success in zones as low as 4 or 5); the higher the zone's number, the greater the adaptability of the plants. In the growing season (from April to September in the northern hemisphere), the average daytime temperature needed is 23 to 27 °C (73 to 81 °F). In regions with low light levels in winter, the sacred lotus has a period of dormancy. The tubers are not cold-resistant if removed from water and exposed to the air; but when kept underwater in soil, the energy-rich tubers can overwinter temperatures below 0 °C (32 °F). If the plants are taken out of the water for wintertime storage (mostly in exceptionally cold climates), the tubers and roots must be stored in a stable, frost-free location, such as a garage, preferably in a cardboard box or container filled completely with vermiculite or perlite. Care must be taken to fully insulate the tubers.
Sources: en.wikipedia.org
In atmospheric sciences, in situ measurements refer to observations of atmospheric properties obtained using instruments placed within the environment being studied. Aircraft, balloons, and rockets are used to carry some of these instruments, allowing for direct interaction with the air to collect data. For example, radiosondes, carried aloft by weather balloons, measure atmospheric parameters such as temperature, humidity, and pressure as they ascend through the atmosphere, while anemometers, typically positioned at ground level or on towers, record wind speed and direction at specific locations. In contrast, remote sensing techniques, such as weather radar and satellite observations, collect atmospheric data from a distance by using electromagnetic radiation to infer properties without direct contact with the atmosphere.
69% support raising the tax rate on income over $250,000. 54% support limiting deductions taxpayers can claim. 52% support raising the tax on investment income. 51% support reducing Medicare payments to high-income seniors. 51% support reducing Social Security payments to high-income seniors. Fewer than 50% support raising the retirement age for Social Security or Medicare, reducing military defense spending, limiting the mortgage interest deduction, or reducing federal funding for low income persons, education and infrastructure.
=== Overt === In overt primary hypothyroidism, TSH levels are high and T4 levels are low. Overt hypothyroidism may also be diagnosed in those who have a TSH on multiple occasions of greater than 5mIU/L, appropriate symptoms, and only a borderline low T4. It may also be diagnosed in those with a TSH of greater than 10mIU/L.
A cubic ton is an antiquated measure of volume, varying based on the commodity from about 16 to 45 ft3 (0.45 to 1.27 m3). It is now only used for lumber, for which one cubic ton is equivalent to 40 ft3 (1.1 m3).
SNP detection through molecular beacons makes use of a specifically engineered single-stranded oligonucleotide probe. The oligonucleotide is designed such that there are complementary regions at each end and a probe sequence located in between. This design allows the probe to take on a hairpin, or stem-loop, structure in its natural, isolated state. Attached to one end of the probe is a fluorophore and to the other end a fluorescence quencher. Because of the stem-loop structure of the probe, the fluorophore is close to the quencher, thus preventing the molecule from emitting any fluorescence. The molecule is also engineered such that only the probe sequence is complementary to the genomic DNA that will be used in the assay. If the probe sequence of the molecular beacon encounters its target genomic DNA during the assay, it will anneal and hybridize. Because of the length of the probe sequence, the hairpin segment of the probe will be denatured in favour of forming a longer, more stable probe-target hybrid. This conformational change permits the fluorophore and quencher to be free of their tight proximity due to the hairpin association, allowing the molecule to fluoresce.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.